Navigation Links
On the road to creating an affordable master instrument

What talented young violinist has not dreamt of playing on a Stradivarius, that non plus ultra of the violin-maker's art? Unfortunately, of course, these instruments are rare, and well beyond the budget of most musicians. "Imitations" of similar tonal quality are therefore very sought-after, and the Empa researcher Francis Schwarze has managed to achieve this feat with the help of a Swiss violin maker. By treating the wood with Physisporinus vitreus, a white-rot fungus which attacks and destroys certain structures in spruce, he was able to create a material with extraordinarily good tonal qualities. So good in fact that the new "fungus violin" put its own role model in the shade. At a specialist conference in 2009 two of the new instruments were compared in a blind test to a Stradivarius and both the jury of experts and the conference audience judged their sound to better than that of the violin made by the Italian Master of Cremona.

Schwarze now intends to develop a standardized biotechnological process so that sufficient fungally-treated wood can be produced to make instruments in respectable numbers. This is the only way that would allow an industrial partner interested in the technology to manufacture the violins on a quasi-"mass-produced" basis. In order to create the necessary bridge between science and industry it is vital to develop technologies which offer potential partners significant commercial advantages. In this case this means standardizing the wood treatment parameters to such an extent that a specific tonal quality can be guaranteed. This is not an easy task to accomplish with a material such as wood which is subject to natural fluctuations in quality.

Generous support from the Walter Fischli Foundation

In the Walter Fischli Foundation the Empa scientist has found financial support which will enable the "fungal violin" project continue. Explaining why he decided to provide funding for Schwarze's work, Walter Fischli, who is co-founder of the biomedical company Actelion and an enthusiastic hobby violinist, says "In my opinion it would have been unforgivable to allow such an interesting project one that so ideally links science and the art of violin making to wither for lack of funding." Fischli hopes that the Empa specialists will finally uncover the secret of why violin makers such as Stradivarius and Guarnerius managed to make instruments of such fantastic quality around 1700. Their craftsmanship is, of course, one decisive and undisputed factor but it seems that the wood they used also played a vital role. "Using modern science to explain the technical details of the material properties is something I find enormously interesting," says Fischli.

Developing a standard wood treatment process in an interdisciplinary way

The project, which commenced at the beginning of September and will run for three years, is led by Iris Brmaud, a specialist in the field of tonal woods. The French scientist is responsible for ensuring that the treatment with the white rot fungi P. vitreus and Xylaria longipes optimally "ennobles" samples of spruce and maple woods. In addition she is already in contact with Michael Baumgartner, the renowned instrument maker from Basel. Under his guidance the "fungus violins" using the treated wood will be created.

Before Empa can take delivery of the first violin, however, numerous tests on both treated and untreated wood samples must be carried out. Experts are currently systematically measuring the density of the wood, the speed of sound in it and its acoustic attenuation. Specialists in the field of ultrasonics are developing methods to determine where the fungus was active and where not. Other scientists expert in optical measurement techniques are using their specialist methods to create images showing how sound is radiated by the different woods and also complete instruments. The final steps should involve collaborations with specialists of psychoacoustics to understand how musicians and listeners perceive these "mushroom violins."

Contact: Prof. Dr. Francis Schwarze
Swiss Federal Laboratories for Materials Science and Technology (EMPA)

Related biology news :

1. Better beer: College team creating anticancer brew
2. Argonne scientists discover possible mechanism for creating handedness in biological molecules
3. Creating ideal neural cells for clinical use
4. Marine microbes creating green waves in industry
5. Marine microbes creating green waves in industry
6. Stimulus-funded university research addressing issues from climate change to cancer, creating jobs and training a new generation of scientists
7. Melting tundra creating vast river of waste into Arctic Ocean
8. Scientists are first to unlock the mystery of creating cultured pearls from the queen conch
9. Forest deal at Copenhagen must avoid creating carbon refugees
10. VAI researchers find long awaited key to creating drought resistant crops
11. Creating a dream breed
Post Your Comments:
Related Image:
On the road to creating an affordable master instrument
(Date:10/29/2015)...  Connected health pioneer, Joseph C. Kvedar , ... health and wellness, and the business opportunities that arise ... Internet of Healthy Things . Long before health ... Dr. Kvedar, vice president, Connected Health, Partners HealthCare, was ... care from the hospital or doctor,s office into the ...
(Date:10/27/2015)... 2015 In the present market scenario, security ... various industry verticals such as banking, healthcare, defense, electronic ... demand for secure & simplified access control and growing ... hacking of bank accounts, misuse of users, , and ... PC,s, laptops, and smartphones are expected to provide potential ...
(Date:10/26/2015)... India , October 26, 2015 ... --> adds ... 2015 to 2021 as well as ... 2015-2019 research reports to its collection ... . --> ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna ... announced today that the remaining 11,000 post-share consolidation ... Purchase Warrants (the "Series B Warrants") subject to ... exercised on November 23, 2015, which will result ... After giving effect to the issuance of such ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... customer, OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 ... Texas facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds ...
(Date:11/24/2015)... Nov. 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... the company,s president and chief executive officer, will present at ... week in New York City . The ... December 1, 2015 at 9:30 a.m. EST. ... the website at least 15 minutes prior to the presentation ...
(Date:11/23/2015)... Nov. 24, 2015 Women with a certain type ... face a higher risk of lung cancer than men with ... week at the annual meeting of the Radiological Society of ... --> --> Lung nodules are small ... solid or subsolid based on their appearance on CT. Solid ...
Breaking Biology Technology: